SEC Filing Update: #INBX Inhibrx Biosciences, Inc. : $88.37

Sector: Healthcare | YTD: 🔼+ 18.05% The SEC disclosed Today (14-AUG-2026) that VIKING GLOBAL INVESTORS LP has INCREASED #INBX Shares by 23.11% 🟢 SCHONFELD STRATEGIC ADVISORS LL also reported an increase in its holdings on the same day. * Previous Holdings: 1.12M Shares * Current Holdings: 1.38M Shares * Increase+259.69K * Increased(%)+23.11% * Ownership: 9.3% * Estimated Investment Value: $23.23M https://www.thinksabio.com/reports/isr/INBX The quarterly average prices of #INBX: Q3 2025: $24.62 Q4 2025: $67.95 Q1 2026: $74.17 📌 Institutional activity in the last 30 days for #INBX: • BANK OF AMERICA CORP DE – Increased holdings by 824,635 shares (03-AUG-2026) • SCHONFELD STRATEGIC ADVISORS LL – Increased holdings by 84,092 shares (14-AUG-2026)